Skip to main content
Swing Capital

Vineet Laboratories Ltd

NSE: VINEETLAB BSE: 543298

Incorporated in 2003, Vineet Laboratories Ltd is in designing, developing, manufacturing of API Intermediates and Bulk Drugs

₹33.8
52W: ₹23.9 — ₹43.8
PE 0 · Book ₹7.4 · +357% vs book
Market Cap₹65 Cr
Stock P/E—Price to Earnings
ROCE28%Return on Capital
ROE89.5%Return on Equity
Div. Yield0%Face Value ₹10

Weaknesses

  • −Stock is trading at 4.46 times its book value
  • −Company has low interest coverage ratio.
  • −Promoter holding has decreased over last quarter: -6.48%
  • −Promoter holding is low: 5.98%
  • −Company has a low return on equity of -21.7% over last 3 years.

Shareholding Pattern

Promoters5.98%
FIIs0.36%
DIIs0%
Public93.67%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters37.5%36.07%▼1.435.85%▼0.235.85%29.26%▼6.615.89%▼13.412.46%▼3.45.98%▼6.5
FIIs0%0%0%0%0%0%0%0.36%▲0.4
DIIs0%0%0%0%0%0%0%0%
Public62.49%63.93%▲1.464.15%▲0.264.15%70.74%▲6.684.11%▲13.487.54%▲3.493.67%▲6.1

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales43.3732.6537.0523.8618.9618.114.087.4417.4215.65
Expenses39.233.2933.6324.6519.2722.2325.127.1314.2413.17
Operating Profit4.17-0.643.42-0.79-0.31-4.13-11.040.313.182.48
OPM %9.61%-1.96%9.23%-3.31%-1.64%-22.82%-78.41%4.17%18.25%15.85%
Net Profit2.42-2.071.92-2.13-1.83-5.71-10.53-0.870.40.85
EPS ₹1.26-1.081-1.11-0.95-2.97-5.48-0.450.210.44

AI Insights

Revenue Trend

TTM revenue at ₹55Cr, down 26.7% YoY. OPM at -9%.

Debt Position

Borrowings at ₹43Cr. Debt-to-equity ratio: 8.60x. High leverage — monitor closely.

Institutional Flow

DIIs: 0% (+0.00pp change). FIIs: 0.36% (+0.36pp change). Promoters hold 5.98%.

Margin & Efficiency

ROCE declining from 0% (Mar 2020) to -28% (Mar 2025). Working capital days: -37.

Recent Announcements